Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.Howard A. Burris, Daniel D. Von Hoff, Malcolm J. Moore et al.|Journal of Clinical Oncology|1997Cited by 5.9k
A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancerMace L. Rothenberg, Daniel D. Von Hoff, Malcolm J. Moore et al.|Annals of Oncology|1996Cited by 569
A single-cell atlas of the healthy breast tissues reveals clinically relevant clusters of breast epithelial cellsPoornima Bhat‐Nakshatri, Harikrishna Nakshatri, Hongyu Gao et al.|Cell Reports Medicine|2021Cited by 121
Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasisSusana García‐Recio, Lisa A. Carey, Markia A. Smith et al.|Nature Cancer|2022Cited by 114
Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohortsSiri H. Strand, Graham A. Colditz, Belén Rivero‐Gutiérrez et al.|Cancer Cell|2022Cited by 88